Richard A Koup

17PUBLICATIONS
332CO-AUTHORS
Nanotoxicology, health and safetyInnate immunityGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 06, 2026
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.

|Jan 27, 2026
Enhanced Clearance of HIV-1 Broadly Neutralizing Antibody VRC07-523-LS During Viremia: Influences on Trial Design and Analysis.

Nicholas M Smith, Brian M Ho, Katharine J Bar

|May 15, 2025
Precise targeting of HIV broadly neutralizing antibody precursors in humans.

Tom G Caniels, Madhu Prabhakaran, Gabriel Ozorowski

|May 15, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.

Jordan R Willis, Madhu Prabhakaran, Michelle Muthui

|Apr 23, 2025
FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting <i>Plasmodium falciparum</i> circumsporozoite protein.

Neville K Kisalu, Lais D Silva Pereira, Jonathan D Herman

|Jan 01, 2025
Vaccination with different group 2 influenza subtypes alters epitope targeting and breadth of hemagglutinin stem-specific human B cells.

Grace E Mantus, Ankita J Chopde, Jason Gorman

Pageof 3

Frequent Collaborators

10 joint publications

Adrian B McDermott

6 joint publications

David Montefiori

5 joint publications

Amarendra Pegu

4 joint publications

Hongmei Gao